Membership

Categories

View All
Autoimmune Diseases Brain Health Cardiovascular Health Metals Microbes Women’s Health

Conditions

View All
Alzheimer’s Dementia Anemia Autism spectrum disorder (ASD) Bacterial Vaginosis Breast Cancer Chronic Pelvic Pain (CPP) Diabetes Type I Endometriosis Erectile Dysfunction Female Infertility Graves Disease Hashimoto’s Thyroiditis Heart Failure Infertility Irritable Bowel Syndrome (IBS)

Definitions

View All
Amsel’s Criteria Blood-Brain Barrier (BBB) Bradford Hill Criteria Coelomic Metaplasia Theory Drug Repurposing  Endometriomas Environmental Theory of Endometriosis Estrobolome Estrogen Estrogen Receptors (ER) Facultative Anaerobes Fecal Microbiota Transplantation (FMT) Genetic and Epigenetic Theory of Disease Gram-Negative Bacteria Hormone Replacement Therapy (HRT)

Guides & Resources

View All
Endometriosis Guide Microbiome Diet for Endometriosis

Interventions

View All
Boric Acid Cholestyramine Clindamycin Clinoptilolite Zeolite Dimethylglyoxime (DMG) Hyperbaric Oxygen Therapy (HBOT) Lactoferrin Low‑Nickel Diet (LNiD) Lugdunin Metformin Metronidazole Phage Therapy Photobiomodulation Probiotics Resistance (Strength) Training

Supplements

View All
Essential Oils Flavones and Flavonols Guar Gum Pueraria Flower Extract (PFE)

Microbes

View All
Escherichia coli (E. coli) H pylori Microsporum canis (M. canis) Pseudomonas aeruginosa Staphylococcus aureus (S. Aureus) Streptococcus agalactiae (GBS) Streptococcus spp. Ureaplasma urealyticum (U. urealyticum)

Metals

View All
Gallium Iron (Fe) Lead (Pb) Metalloestrogens Nickel Nickel in Escherichia coli: Metabolic and Pathogenic Roles Zinc

Research Feeds

View All
Diagnosis of the menopause: NICE guidance and quality standards Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer Dietary Intake and Ovarian Cancer Risk: A Systematic Review Maternal Iron Deficiency Anemia Affects Postpartum Emotions and Cognition Evidence for the Use of Complementary and Alternative Medicine for Pelvic Inflammatory Disease: A Literature Review Prevalence of hot flushes and night sweats around the world: a systematic review Hormone therapy and the risk of stroke: Perspectives ten years after the Women’s Health Initiative trials Vaginal microbiome of women with premature ovarian insufficiency: a descriptive cross-sectional study Exercise for dysmenorrhoea Black cohosh (Cimicifuga spp.) for menopausal symptoms. Hormone replacement therapy for women previously treated for endometrial cancer

Gut Microbiota in Graves’ Disease and Graves’ Orbitopathy: Distinct Microbial Signatures and Implications

Our team reviews, analyzes, and summarizes the latest health and nutrition studies to help you be healthier. Updated daily.

Premium Content

We are an entirely self-funded, with no third-party ads or ties to food and supplement companies.

This study identified distinct alterations in gut microbiota composition and function in Graves’ disease and Graves’ orbitopathy patients compared to healthy controls, highlighting specific microbial taxa and metabolic pathways that may contribute to disease mechanisms and serve as future biomarkers.

All articles (A-Z)

A B C D E F G I M O P S T U V
G
Gut Microbiota in Graves’ Disease and Graves’ Orbitopathy: Distinct Microbial Signatures and Implications
A
Altered Composition of Microbiota in Women with Ovarian Endometrioma: Microbiome Analyses of Extracellular Vesicles in the Peritoneal Fluid
A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women
A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models
M
Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population
G
Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study
Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson’s Disease
Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer’s Disease
A
Analysis of subgingival microbiome of periodontal disease and rheumatoid arthritis in Chinese: A case-control study
P
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
F
Fecal Microbiota Changes in Patients With Postpartum Depressive Disorder
T
The Vaginal Microbiome as a Tool to Predict rASRM Stage of Disease in Endometriosis: a Pilot Study
C
Classifying dementia progression using microbial profiling of saliva
S
Self-Balance of Intestinal Flora in Spouses of Patients With Rheumatoid Arthritis
C
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
Characterization of the Vaginal Microbiome in Women with Infertility and Its Potential Correlation with Hormone Stimulation during In Vitro Fertilization Surgery
M
Microbiome Profile of Deep Endometriosis Patients: Comparison of Vaginal Fluid, Endometrium and Lesion
A
Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson’s disease
C
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study
M
Microbiota composition and distribution along the female reproductive tract of women with endometriosis
S
Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer’s Disease
G
Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease
C
Correlation of fecal metabolomics and gut microbiota in mice with endometriosis
G
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
C
Changes in the vaginal microbiota associated with primary ovarian failure
M
Microbiome of the lower genital tract in Chinese women with endometriosis by 16s-rRNA sequencing technique: a pilot study
C
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
T
The impact of intestinal microbiota on weight loss in Parkinson’s disease patients: a pilot study
A
Altered gut microbiota in Parkinson’s disease patients/healthy spouses and its association with clinical features
S
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
G
Graves’ Disease Gut Microbiota Signature: Key Microbial Changes in Autoimmune Thyroid Disease
T
The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ
A
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
G
Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
D
Diversity of vaginal microbiome and metabolome during genital infections
A
Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort
G
Gut Microbial Composition and Function Are Altered in Patients with Early Rheumatoid Arthritis
T
The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls
A
Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
O
Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients
E
Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota
A
Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota
M
Mild cognitive impairment has similar alterations as Alzheimer’s disease in gut microbiota
A
Analysis of the Gut Microflora in Patients With Parkinson’s Disease
M
Molecular detection of microbial colonization in cervical mucus of women with and without endometriosis
A
Analysis of Salivary Microbiome in Patients with Alzheimer’s Disease
O
Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis
E
Effect of endometriosis on the fecal bacteriota composition of mice during the acute phase of lesion formation
U
Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism
D
Dysbiosis of gut microbiota in a selected population of Parkinson’s patients
A
Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease
G
Gut microbiota in Parkinson’s disease: Temporal stability and relations to disease progression
T
The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function
D
Dysbiotic Subgingival Microbial Communities in Periodontally Healthy Patients With Rheumatoid Arthritis
S
Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health
E
Endometriosis induces gut microbiota alterations in mice
G
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
V
Variations in oral microbiome profiles in rheumatoid arthritis and osteoarthritis with potential biomarkers for arthritis screening
I
Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis
B
Breast cancer in postmenopausal women is associated with an altered gut metagenome
T
The nasal and gut microbiome in Parkinson’s disease and idiopathic rapid eye movement sleep behavior disorder
A
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
G
Gut microbiota in patients with Parkinson’s disease in southern China
A
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
G
Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study
A
Alterations of the Gut Microbiota in Hashimoto’s Thyroiditis Patients
M
Molecular Alteration Analysis of Human Gut Microbial Composition in Graves’ disease Patients
A
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
G
Gut microbiome alterations in Alzheimer’s disease
P
Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome
A
A comprehensive analysis of breast cancer microbiota and host gene expression
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
F
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients
G
Gut microbiota in Parkinson disease in a northern German cohort
S
Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features
D
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome
M
More than constipation – bowel symptoms in Parkinson’s disease and their connection to gut microbiota
B
Breast tissue, oral and urinary microbiomes in breast cancer
M
Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients
Molecular detection of intrauterine microbial colonization in women with endometriosis
S
Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls
G
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
Gut microbiota in early pediatric multiple sclerosis: a case-control study
M
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
T
The microbiome of the oral mucosa in irritable bowel syndrome
A
Alterations of the human gut microbiome in multiple sclerosis
I
Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children
A
An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis
C
Colonic bacterial composition in Parkinson’s disease
D
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters
F
Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis
A
Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes
G
Gut microbiota are related to Parkinson’s disease and clinical phenotype
M
Microbial dysbiosis is associated with human breast cancer
F
Fecal microbiota imbalance in Mexican children with type 1 diabetes
O
Oral status in patients with early rheumatoid arthritis: a prospective, case-control study
G
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study
F
Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome
Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.

Yes, I want to help shape the future of microbiome medicine.